A (4:56)

And it made you realize. I'm going to start a podcast about this. What gap in the public discourse were you hoping to fill with this podcast? GLP1 Truth Serum.

B (5:07)

Honestly, I have to tell you the story, which is that I had. I have a friend, a dear friend named Isabel. And I only see Isabel once every few months. She lives in Puerto Rico. And every time she came to visit, I would be. Apparently I would just be raving about how frustrated I was by the lack of critical coverage about GLP1s by media. And, you know, and literally right before the podcast, she said, you need to do a project. I am not listening to one more conversation. It has been months, months and months and months of you talking about this and I just need you to do something about it. And she said, she even gave me the names, like why don't you call it GLP1 True Serum or something? She's, she's like this kind of natural master marketer. So, yeah, I mean, basically as a journalist myself, I was finding all of these moments that I would consider newsworthy that were not being covered. I mean like one, one example is when for like, you know, One of the GLP1 manufacturers would say something really, in my opinion, over the top, little bit edging on unethical, like we're going to end weight stigma or they would suggest that they're going to end weight stigma. And I would sort of say, you know, what do they mean? Is there a value proposition that they're going to get rid of every single fat adult and child? Is that how they're going to end weight stigma? Because this is the mechanism of action that's happening, right? This is what they do. So I was very alarmed by marketing, you know, terms and suggestions like that. And what I was finding was there was no interest in critically engaging, engaging with the marketing thing. I mean, thankfully, a few months after my own experience, which was January 2024, where I'm getting these emails, thankfully, ultimately the Washington Post, you know, covered the story and broke it wide open. But I, I had been really troubled by how there was a big focus on almost trying to make the body positivity movement, which is a largely woman led grassroots movement, seem toxic. And that seemed to be the only thing that the mainstream press was interested, was praising GLP1s and throwing this incredibly important historical movement under the bus.

A (7:22)

Who did you decide to talk to as a journalist? Who did you know, you needed in this show?

B (7:28)

Well, I actually reach out to people who were, frankly, I mean, I work very, very closely with many, many people who are deeply impacted by weight stigma and who are deeply impacted by diet culture. And so my audience, who I would consider the vulnerable population that is being Left behind by GLP1 discourse, I asked them who did they want to hear from and they unequivocally said people were doctors. And I think that it was this sense that there was this sort of ubiquity and you like there was this ubiquity of medical agreement. Right. That was kind of the sense that people had. And when they had concerns as people with eating disorder histories or as people who maybe don't believe in intentional weight loss, both from a personal perspective and From a data perspective, they felt. They felt the word is gaslit. They felt confused because of the way in which the marketing is. So I call it lab coat washing. The marketing is so lab coat washed. It's really difficult to sort of have a moment where you think, well, if every doctor believes this is positive, that am I the problem? Do I just need to cave? Do my values need to change? And so what I started to do was look at people who are clinicians and talk to people who are clinicians. And I've talked to people, you know, like a friend who's a psychiatrist at Georgetown and adolescent psychiatry, Dr. Corey Williams. I've talked to Dr. Lauren Hartman, who's also in pediatrics. I've talked to a few people who are in the eating disorder world long term and who really understand the fallout of what intentional weight loss, especially rapid intentional weight loss, can do to a person.

A (9:11)

My guest is weight based discrimination speaker, author and Forbes contributor Virgie Tovar. She's the host of GLP one True Serum, a new podcast, except for exploring the weight loss drugs. Listeners, we'd like to hear from you. When did you first hear about Ozempic, Wegovy, Mounjaro, and other GLP1s? Have you considered using one of these weight loss drugs for yourself? Why or why not? If you've used one, how have you felt after using the medications? Did it work for you? Did it work for your body image? Or is it the same? 2124-3396-9221-2433 wnyc Virgin the first episode, you talk about the history of weight loss drugs and appetite suppressants. I want you to put this in perspective for us. How do GLP1s function differently than some of the drugs we've seen rise and fall in the past?

B (10:05)

Yeah, I mean, this is something I drive home a lot in the podcast, which is that GLP1s have changed the how but not the what. And so the what Is appetite suppression funded? Fundamentally, all diets work by restricting calories in one way or another. So in that way, GLP1s are not any different historically than any other medication because they work through the same mechanism. However, they do it differently. The method of doing that is different. Right. So a lot of people don't know this, but when you feel hungry, it's a hormone that's being emitted and sent into your brain that tells you, I'm hungry. And there are sensations that we associate with that hormone. And then there's another hormone that's emitted when you're full and it goes to your brain. They're processed each separately in different parts of the body, but just kind of know there's a fullness hormone and there's a hunger hormone. What GLP1s do is they kind of, they've created a synthetic version of the fullness hormone. So it sends that almost like, you know, the feeling you have after Thanksgiving dinner. Sometimes times 2, 3, 4, 5, 6, 7 times more intense than that. They send that amount of hunger rather, rather fullness signal to your brain. So it sends a signal that says I am very full. Even though you have maybe eaten nothing or maybe eaten just a couple of bites. And it creates that hormone when there's a lot of. It can create aversion to food, it can create a change in the taste of food. And the other thing that's important to understand is, I mean, this is one of the things I talk about with one of my guests, Dr. Corey Williams, who's a Georgetown psychiatrist. You know, there are implications for that, you know, extended state of deprivation which, which we call starvation states. Right. So starvation state is when you're in a consistent caloric deprivation. It's not literally you don't eat any food, but when you're in that state, you're at risk for developing something called anhedonia, which is when you have difficulty feeling pleasure because food deeply connected to the pleasure and reward centers in our brains. So one of the things that's potentially A risk for GLP1 users is if they have pre existing psychiatric vulnerabilities. This could land them, you know, in the emergency room or hospitalized because of this impact that caloric deprivation has on mood.

A (12:41)

Let's take a call. This is Wendy online too. She's calling in from Westchester. Hi Wendy, thank you for taking the time to call, all of it. You're on the air.

B (12:51)

Hi.

C (12:52)

I totally respect what your guest is saying, but I want to ask her her opinion about this. There seems to be a lot of body positivity influencers online who have, who have a lot of followers and who subsequently use these GLP1s and lose a lot of weight. And they say they're much happier. And so I. And then they disappoint all their followers and it's very difficult. And I'm just wondering if a lot of these people are body feel, you know, promote body positivity because they are overweight and they can't lose weight and it's kind of justifying it. And then when people are able to lose weight, they seem much happier. And I just like to hear her response.

A (13:44)

Virgie, go ahead.

B (13:46)

Yeah, I mean, I think there's a variety of types of people who are content creators in the body positivity movement. And, you know, the people who have very strong embedded values around this, they just aren't getting any coverage. Right. Because it's not very interesting news to hear person, you know, maintain same values for 10 years. Right. Like somebody like me and a number of my colleagues who have not changed their stance, have not taken GLP1s. But to respect that there's a diversity of reasons why people come to body positivity and. Absolutely, Wendy. One of one of those archetypes is a person who maybe felt like weight loss previous to GLP1s, did not feel accessible and maybe felt like, you know, deep down that they really wanted that, but that they were going to maybe try new to try different values on and see how they fit. So I don't want to downplay that there's this diversity of people for whom, you know, weight loss is or is not a priority because that's, that's the reality of the situation. I think fundamentally my, my overall response is that it's very difficult to look at GLP1s in a vacuum. You can't just look at GLP1s without looking very, very closely at our culture of weight stigma and the amount of pressure that GLP1 marketing has placed not only on all the culture. And I think about moments like, you know, I'm in and I walk out of the subway and every Single ad for 30ft is a GLP1 ad. So that kind of pressure. But I think it's important to understand, like I was mentioning earlier, our community was explicitly targeted for a campaign of. That was very, very, I would say, enthusiastically attempting to dismantle publicly this movement. And I believe that it was a marketing strategy. So I think it's important to understand that these. Absolutely. I don't want to downgr anybody's values or priorities, but it's important to understand that one, we live in a culture that is extremely fat phobic. So it's very difficult to say no to that, whether you're a body positive influencer or not. And then when you add the layer of GLP1 targeting for our movement, I think you've got a situation where it's just important to think about all of these factors as we're looking at this.

A (16:16)

You know, GLP1s such as Ozempic and Mugovy were originally intended to treat patients with diabetes and They've been life changing for many people. They also happen to aid in weight loss. Here's a question. How do you balance the good medications, what they may do, which is good, with the harm they may do for people who want to engage in body neutrality?

B (16:41)

Yeah, I mean, I don't think it's actually that complicated. I mean, I think there's lots of, lots of things in our culture that are really fantastic, for one thing, and maybe should not be used for other cases. I also think I kind of want to specifically say, I think of myself as an advocate for vulnerable populations, which is probably, I would say probably 1 in 4, 1 in 5. The people who have these eating disorder histories, people who have body image disturbance histories are the communities that we all have a friend, we all have a family member who is in this community. These communities are not being properly considered when we're talking about this medication. So I just kind of want to contextualize that. I absolutely believe in sort of the ways in which GLP1s. I've seen the ways in which GLP1s really help people with diabetes manage their A1Cs, and I think that's fantastic. And I don't think that means we need to throw the baby out with the bathwater.

A (17:44)

It's really interesting. In one of your more recent episodes, you sat down with Dr. Laura Hartman, a pediatrician who talked about prescribing GLP weight loss drugs to children. What was her biggest concern? We're going to play a clip from the, from the podcast, but what was her biggest concern?

B (18:01)

Yeah, I mean, I think that her biggest concern was that the medications, just the existence of the medications themselves and the fact that doctors were suggesting them were creating and perpetuating and perhaps worsening the message that something is wrong with your body when you're a kid.

A (18:19)

Let's take a listen. This is from GLP1 Truth Serum.

D (18:23)

Amongst my colleagues, amongst other adolescent medicine doctors and other adolescent medicine doctors specifically with eating disorder expertise, there's a lot of concern and a lot of kind of holding our breath and feeling really anxious about these medications and really about the rise and how quickly they are being prescribed to kids. So there was a study in 2024 that said the rate had increased by 600% prescriptions for kids and young adults over the past three years. And I can just imagine what that looks like today.

B (19:01)

Right.

D (19:01)

Like that was in 2024. And so these are being prescribed to kids. And when we think about adolescence and think about childhood, like that is a time where you're supposed to be growing, right? Your bodies are developing. We're supposed to be going through puberty and having your brain develop and having your bones become strong and gain adult height. And so I think the, the panic is when we think about what is happening when we are suppressing weight at a time when kids are supposed to be growing and developing and gaining weight. And the truth is we don't have that data. Like, we don't know what happens when you are suppressing weight for these kids at a time when they're supposed to be growing.

A (19:51)

That's from GLP1 Truth Serum, the podcast. My guest is Virgie Tovar. She is the host of the podcast. Let's talk to Megan, who's calling in for Murray Hill. Hi, Megan, thank you so much for calling all of it. You're on the air.

C (20:05)

Thank you. I wanted to say the first time I heard of a GLP one was, I think it was two years ago, a Super bowl ad. And the ad started with, the weight loss system is broken. It's a billion dollar industry. Aren't you sick of this? And then the ad ended with, try our weight loss solution. We are the drug that's going to help you. And it was like a hook, line and sinker. And I couldn't believe they thought the audience was so naive to hear you start an ad saying, this is bad, bad, but try ours, because ours is good.

A (20:32)

Megan, thanks for calling in. Your thoughts. Virgie?

B (20:37)

Oh, yeah. I mean, this kind of, you know, it's really, it's a, it's a brilliant rhetorical move. And I kind of want to say anecdotally, that exact super bowl ad that Megan is referencing, I was just talking to a colleague who works at an eating disorder clinic and she was saying that the day that they got the most calls was after that super bowl ad. So just to talk about how this doesn't just have like a theoretical ripple, this has real life consequences for people who are in these vulnerable populations. But I kind of want to say, like, you know, fundamentally, what GLP once had to do because the body positivity movement had been so successful at dismantling diet culture is they had to fundamentally say, we're not diet culture. And this is where all this kind of, you know, this co optation of weight stigma language, they co op the critique of diet culture, even though they're part of diet culture. And what they're doing is they're setting the theoretical parameters and they're giving consumers talking points. So even if you're not Taking GLP ones, you're bringing these talking points into conversations with people, which is just brilliant marketing. But I kind of want to conclude by saying, right, we cannot allow pharmaceutical companies to set the rhetorical parameters of this convers. We cannot treat this as if it's total. Like we've never seen anything like this before when we know that appetite suppressant suppressants have had over 100 years to prove that they work. And there have been various iterations. This is just the newest one. But again, I think, I think Megan brings up a really good point that this, this circular logic of how terrible weed stigma is so bad even though we're monetizing it, diet culture is terrible, even though we're part of it, but we're not doing. And so it can. Again, I think that sense of, like I was saying, that sense of confusion that a lot of people feel, I think that's in some ways part of the point of, of the marketing.

A (22:44)

We're talking about a new podcast called GLP1 Truth Serum with its host, Virgie Tovar. We're going to take more of your calls and we'll have more with Virgie after a quick break. This is all of It. You're listening to all of it on wnyc. I'm Alison Stewart. My guest is Virgie Tovar. She is the host of a new podcast called GLP1 Truth Serum. We've been getting a lot of calls about people saying it's changed my life. I've been very happy on it. But I did want to talk to Stephanie from Nourishell because she introduces the nutritional aspect that goes along with the drugs. Hi, Stephanie. Thank you so much. Would you share your opinion with us?

B (23:33)

Hi.

E (23:34)

Hi. Thank you for taking my call. Yeah, not at all removing anything that you are all discussing, but adding to rather is the aspect. I work in the medical field and I see a lot of people on this medication. I'm not a provider myself, but. And while I really praise it to help people bring down their A1C to help people, you know, in that respect, it seems to me that while it's a great support, there is no talk about nutrition, there is no discussion with that person who has an A1C or problem with cholesterol or anything like that. We're not touching upon the foundation of it. Right. So the malnutrition is what's causing a lot of these problems. Not all of them, but a lot of them. And I feel like there is no discussion about that. There's no discussion about how to teach.

C (24:26)

People how to eat crack.

E (24:27)

And by that I mean differentiate between processed and non processed foods, whole foods, grains, vegetables. You know, the old school thing, the chart that we used to be in our, in our schools and we learned about it seems to be there's a void. It's just like, nope, you know, you can now you can only eat one McDonald's meal instead of three because you won't have appetite to eat all three or something. You know, it doesn't, doesn't say, hey, you know, let's talk about eating well as a long term goal rather than always being on this medication.

A (24:58)

Stephanie, thank you for sharing your opinion. What do you think about that, Virgie?

B (25:04)

Yeah, I mean, I think Stephanie brings up an interesting point around nutrition. Right. Like there's all of these absences in the conversation. And I think it's important to really understand that the people who are saying this medication is amazing and it changed my life. There's a self selection bias here. Right. Like, and I think what we need to understand is that when people are very attached to weight loss, and I'm someone who historically was exceedingly attached to weight loss, it was a very, very big part of my values, both as an individual from a health perspective, but also from every other perspective. I felt that weight loss was, it was a very important part of my life. And so it's important to understand that the people who are going on GLP1s are likelier to be lifelong weight cyclers are likelier to be the people who when there is failure or problems, they're likelier to blame themselves. And I don't want for those errors and those problems, those failures. And I don't want to paint with a broad brush that is not everyone. But I'm just speaking from personal perspective as someone who maybe 15 years ago would have very happily lined up to take GLP1s and not been concerned at all about any of the warnings or any of the sort of the starvation state, the consistent starvation state mentioned earlier. It's important to understand that the, like, the presence of that voice and the loudness of that voice does not mean that we should not be critically considering other populations who maybe don't have that commitment. And I kind of want to say, even for people who love GLP1s, there are existential concerns that are going to need to be addressed for them too. And that includes things like most people go off of GLP1s by year one. The research I have is 71% go off by year one one 80% by year two. I also the other problem is these medications plateau after a certain point. So when we're talking about taking these medications for life, even for someone who has theoretically consented to that, what is their dosage going to look like in two years? In four years? In 10 years? And then we're talking about not only dosage and impact, but we're talking about cost. And so there are existential. I mean again, another one which I mentioned earlier was mood, right? Like how being on GLP1s impacts your mood. Even the people who invented WeGovy and Ozempic have mentioned that there are concerns that they have users who may develop almost like existential ennui, like boredom because of how little food they're eating and how connected food is to reward center. So I just want to say, you know, whether you're pro Geo or anti GLP1 or something in between, these are very important long term questions that need to be looked at.

A (28:06)

If you are interested in the long term questions, you should listen to Virgie Tovar's podcast, GLP1 Truth Serum. Virgie, thank you so much for calling. We really appreciate it. And thanks to everybody who called in.

B (28:18)

Thank you.

A (28:19)

Since WNYC's first broadcast in 1924, we've been dedicated to creating the kind of content we know the world needs. In addition to this award winning reporting, your sponsorship also supports inspiring storytelling and extraordinary music that is free and accessible to all. To get in touch and find out more, visit sponsorship.wnyc.org did you know that.

B (28:42)

Skincare can start in the laundry room? Allfreeclear is the number one laundry detergent brand recommended by dermatologists, allergists and pediatricians, pediatricians for sensitive skin. Allfreeclear is 100% free of dyes and perfumes. It provides an effective clean that's gentle on skin while removing impurities like dirt and body oil without leaving irritating residues. Plus, all freeclear liquid is safer choice certified by the US EPA for a clean you can feel good about. All you need is all free clearance.